Clinical Trials Sponsored by A. Vogel

Total 6858 results

University of Michigan Rogel Cancer Center

Completed

Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients

HPV | Squamous Cell Carcinoma of the Oropharynx

United States
University of Michigan Rogel Cancer Center

Withdrawn

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
University of Michigan Rogel Cancer Center

Completed

Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation (IC-Green)

Hepatic Irradiation

United States
University of Michigan Rogel Cancer Center

Completed

Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer

Non-Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Completed

The Validation of a Novel Adherence Method for Oral Oncolytics

Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas

Glioma | Diffuse Intrinsic Pontine Glioma

United States
University of Michigan Rogel Cancer Center

Terminated

Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy

Urothelial Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant

Hematologic Neoplasms | Graft vs Host Disease | Non-Neoplastic Hematologic and Lymphocytic Disorder

United States
University of Michigan Rogel Cancer Center

Completed

Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell Transplantation

Patients Undergoing Bone Marrow Transplant (BMT)

United States
University of Michigan Rogel Cancer Center

Completed

Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas

Lymphoma, T-Cell

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

Sarcoma | Neuroblastoma | Wilm's Tumor

United States
University of Michigan Rogel Cancer Center

Terminated

Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer

Breast Cancer | Insomnia

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response

Pancreatic Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)

Hepatocellular Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer

Head and Neck Squamous Cell Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma

Esophageal Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia

Acute Myelogenous Leukemia

United States
University of Michigan Rogel Cancer Center

Completed

Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients (HUM21469)

Nausea | Vomiting | Terminally Ill

United States
University of Michigan Rogel Cancer Center

Terminated

A Study of Mitomycin C, Irinotecan, and Cetuximab

Colorectal Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)

Cancer of Larynx

United States
University of Michigan Rogel Cancer Center

Terminated

Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)

Bladder Cancer | Urothelial Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy

Head and Neck Squamous Cell Carcinoma

United States
University of Michigan Rogel Cancer Center

Completed

Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Early Assessment of Treatment Response Using Functional Diffusion Mapping

Prostate Cancer

United States
University of Michigan Rogel Cancer Center

Withdrawn

A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

Cancer of Head and Neck

United States
University of Michigan Rogel Cancer Center

Completed

Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

Nasopharyngeal Cancer | Fibrosarcoma | Wilms Tumor | Brain Tumor, Recurrent | Carcinoma, Round Cell

United States
University of Michigan Rogel Cancer Center

Completed

Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC

Extensive-Stage Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Completed

A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer

Head and Neck Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer (EBUS)

Non-Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

Myelodysplastic Syndromes | Myeloproliferative Disorders | Lymphoma, Malignant | Waldenstrom's Macroglobulinemia | Myeloma, Plasma-Cell

United States
University of Michigan Rogel Cancer Center

Completed

Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma

Multiple Myeloma

United States
University of Michigan Rogel Cancer Center

Completed

Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine

Breast Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin's

United States
University of Michigan Rogel Cancer Center

Completed

Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma

Esophageal Cancer

United States
University of Michigan Rogel Cancer Center

Terminated

Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus

Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus

United States
University of Michigan Rogel Cancer Center

Terminated

Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin's

United States
University of Michigan Rogel Cancer Center

Terminated

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Lymphoma, Low-Grade | Lymphoma, Non-Hodgkin's

United States
Qmed Consulting A/S
Ambu A/S

Completed

Post Market Study to Collect Data for Software Recognizing the Anatomical Structures During Bronchoscopy.

Pulmonary Disease | Tumor | Hemoptysis

Denmark
University of Michigan Rogel Cancer Center
GlaxoSmithKline

Active, not recruiting

Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma

Multiple Myeloma

United States
University of Michigan Rogel Cancer Center
Exelixis

Terminated

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Prostate Cancer Metastatic

United States
University of Michigan Rogel Cancer Center
Novartis

Withdrawn

RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.

Chronic Myeloid Leukemia

United States
University of Michigan Rogel Cancer Center
GlaxoSmithKline

Completed

Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center
Pfizer

Terminated

Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma

Bladder Cancer

United States
University of Michigan Rogel Cancer Center
Takeda

Withdrawn

Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

United States
University of Michigan Rogel Cancer Center
Exelixis

Active, not recruiting

Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy

Advanced Adult Hepatocellular Carcinoma

United States
University of Michigan Rogel Cancer Center
Sanofi

Terminated

Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

Prostate Cancer

United States

Clinical Trials Sponsored by A. Vogel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations